ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenNeurimmune AG
Neurimmune AG Logo
Verified· 4 sources

Neurimmune AG

Summary

About the company

Neurimmune AG is a biopharmaceutical company that translates human immune memory into therapeutic antibodies and develops drug candidates for central nervous system and protein-aggregation diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis, ATTR cardiomyopathy, spinal cord injury and type‑2 diabetes.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered3
Antibody therapeutics
Antibody therapeutics for protein aggregation disorders, in particular against misfolded or aggregated proteins in the brain, heart and other organs.
Drug candidates in clinical development
Drug candidates for ATTR cardiomyopathy, amyotrophic lateral sclerosis and other protein aggregation disorders in the phases from Discovery to Phase 3.
Reverse Translational Medicine™ (RTM™)
Research platform for the discovery of fully human therapeutic antibodies from genetic blueprints of immune cells of older human subjects.
Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 1 reviews across all connected sources

Sources
GGoogle51
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

July 24, 2026Media
Neurimmune erhält bis zu 425 Millionen Dollar für Cliramitug
punkt4.info
February 10, 2024Media
Ämterkumulation: Alzheimer-Professor wird zugleich Firmenchef
nzz.ch

Knowledge

No knowledge articles yet

Once Neurimmune AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Neurimmune AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Neurimmune AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Neurimmune AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 18
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-164.102.684
Founded
2017 · 9 years
Last commercial register change
August 9, 2022
Employees
11 to 20

Similar companies

IB
Inthera Bioscience AG
Zurich
IR
IBM Research GmbH
Rüschlikon
EB
European Biostasis Foundation
Rafz
SO
SwissDrones Operating AG
Zurich